Catheters Market Size and Forecast (2025–2033)

The global catheter market is entering a dynamic phase of expansion, supported by technology breakthroughs, the rising global burden of chronic illnesses, and a dramatic shift toward minimally invasive procedures. According to Renub Research, the market was valued at US$ 25.32 billion in 2024 and is projected to reach US$ 51.65 billion by 2033, growing at a CAGR of 8.24% from 2025 to 2033.

From cardiovascular intervention and urinary drainage to diagnostic precision and life-saving emergency medicine, catheters remain an indispensable part of modern clinical care. Their evolving design—more flexible, safer, and biocompatible—is opening new avenues for medical innovation and patient comfort.

Understanding the Role of Catheters in Healthcare

Catheters are flexible medical devices inserted into the body to perform essential functions: draining fluids, administering medications, or monitoring physiological conditions. These devices are typically made from silicone, rubber, or specialized medical-grade plastics and are inserted through blood vessels, the urethra, or directly into body cavities.

In hospitals around the world, catheters support several critical functions:

Urinary catheterization during surgery or in patients with retention

Cardiovascular catheterization for diagnostics, pressure monitoring, and drug delivery

Dialysis catheters for patients with renal failure

Intravenous catheters for fluids, nutrition, and chemotherapy

This versatility has established catheters as a foundational tool of medical practice, contributing significantly to improved recovery times, enhanced diagnostic accuracy, and life-sustaining therapies.

Key Growth Drivers of the Global Catheter Market

1. Rising Incidence of Chronic Diseases

Global health trends show a sharp rise in lifestyle-linked and age-related chronic illnesses such as diabetes, kidney failure, and cardiovascular diseases. These conditions frequently demand repeated or long-term catheter usage.

Cardiovascular diseases claim 18 million lives annually

Cancers account for 9 million deaths each year

Chronic respiratory diseases cause 4 million deaths

Diabetes results in 2 million deaths

The growing elderly population further intensifies demand for catheter-based therapies such as hemodialysis, angioplasty, and pressure monitoring. As people live longer with chronic conditions, the need for consistent and reliable catheter intervention rises steadily.

2. Technological Advancements and Innovation

Product innovation is reshaping the catheter landscape. Modern catheters are more flexible, resistant to infections, and superior in performance compared to earlier generations.

Recent advances include:

Bioabsorbable catheters that dissolve in the body

Antimicrobial coatings to minimize infection risks

Enhanced durability and steerability for complex cardiovascular procedures

One notable innovation is the EMBOGUARD™ Balloon Guide Catheter, introduced in September 2024, designed to control local blood flow and reduce clot fragmentation during mechanical thrombectomy.

Such innovations reduce recovery times, improve procedural success rates, and expand the range of catheter-based applications—directly propelling market growth.

3. Growing Demand for Minimally Invasive Procedures

Minimally invasive procedures have transformed healthcare by reducing pain, hospital stay duration, and recovery time. These surgeries rely heavily on catheters to guide instruments, deliver medications, and perform diagnostics.

In the U.S. alone, 26.2 million minimally invasive aesthetic and surgical procedures were performed in 2023, according to the American Society of Aesthetic Plastic Surgeons.

As patients and healthcare providers increasingly prefer procedures with lower risks and faster outcomes, catheter utilization continues to rise worldwide.

Regional Market Outlook

Germany

Germany is a central hub in the European catheter segment, backed by world-class healthcare infrastructure and strong R&D. An aging population and high prevalence of cardiovascular and urinary disorders drive steady demand.

A major milestone came in June 2023 when Biotronik launched its multifunctional Oscar catheter, boosting Germany’s leadership in vascular intervention innovation.

China

One of the fastest-growing catheter markets globally, China benefits from:

Massive investments in healthcare modernization

Rising chronic disease rates

Adoption of advanced diagnostic and interventional technologies

Local manufacturing strength also enables China to supply cost-efficient products domestically and abroad. In August 2023, China approved the Novasight dual-mode intravascular imaging catheter, marking a leap forward in cardiovascular imaging.

Brazil

Brazil dominates the Latin American catheter market. Urbanization, improved access to care, and a rising preference for minimally invasive treatments have fueled adoption.

A landmark was achieved in September 2023 when Endovastec’s Reewarm™ PTX Drug-Coated Balloon catheter was successfully implanted in Brazil for the first time—enhancing the nation’s presence in advanced catheter therapy.

United Arab Emirates

The UAE stands out in the Middle East due to strong healthcare investments and a booming medical tourism industry. Lifestyle-related diseases such as diabetes and heart disease significantly boost catheter usage.

In February 2024, Zylox-Tonbridge received approvals for five catheter-related devices, cementing the UAE’s role in medical technology integration.

South Africa

South Africa leads the African market, supported by improvements in healthcare infrastructure and rising incidences of kidney and cardiovascular diseases.

In November 2022, Coloplast introduced a specialized intermittent catheter aimed at reducing urinary tract infections—an important advancement in the region’s patient care standards.

Company Developments: A Competitive Landscape

The global catheter market is highly competitive, with major players advancing technologies and expanding their portfolios.

Abbott Laboratories

Recent milestones include:

FDA approvals in February 2023 for its Sensor Enabled™ TactiFlex Ablation Catheter

The Amulet™ LAA Occluder outperformed competing devices in an August 2021 clinical study

Continued innovation in atrial fibrillation treatment technologies

Becton Dickinson (BD)

BD has launched several breakthrough products:

BD PosiFlush SafeScrub flush syringe (May 2023)

Advanced vascular access ultrasound system (Nov 2023)

First peer-reviewed research on midline catheters

BD continues to focus on improved safety and ease of use in vascular access technologies.

Boston Scientific

Boston Scientific is strengthening its global catheter portfolio through acquisitions and clinical approvals:

Acquisition of Acotec Scientific Holdings (Dec 2022)

FDA approval for FARAPULSE™ PFA System (Jan 2024)

FDA approval for AGENT™ Drug-Coated Balloon (Mar 2024)

Teleflex Incorporated

Teleflex achieved multiple regulatory milestones:

FDA approval of Triumph Catheter (Feb 2023)

New PICC insertion technologies: Arrow® VPS Rhythm® DLX and NaviCurve™ Stylet

Launch of a clinical registry for MANTA™ Vascular Closure Device

Medtronic Plc.

Medtronic continues leading the electrophysiology space:

FDA approval for PulseSelect PFA System in December 2023

CE Mark for Affera™ Mapping & Ablation System in March 2023

Cryoablation approvals for pediatric AVNRT treatment

Johnson & Johnson

J&J MedTech is expanding aggressively:

Acquisition of Laminar Inc. for $400 million (Nov 2023)

CE Mark for VARIPULSE™ PFA Platform (Feb 2024)

New research showcasing long-term catheter ablation outcomes

Edwards Lifesciences

Edwards continues to expand its transcatheter therapies:

FDA approval for EVOQUE therapy (Feb 2024)

COMMENCE study results highlight durability of RESILIA tissue

Stryker Corporation

Stryker is advancing surgical navigation:

Launch of ExcelsiusGPS—a fully autonomous navigation system (Aug 2023)

Opening of an advanced Neurovascular lab in India (Dec 2022)

Market Segmentation

By Type

TAVR

TMVR

TPVR

By Material

Mechanical tissue

Biological tissue

By End-User

Hospitals

Ambulatory surgical centers

Others

By Product

Transfemoral approach

Transapical approach

Transaortic approach

Others

By Application

Aortic Stenosis

Aortic Regurgitation

Others

By Region

North America: U.S., Canada

Europe: France, Germany, Italy, Spain, UK, Belgium, Netherlands, Turkey

Asia-Pacific: China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand

Latin America: Brazil, Mexico, Argentina

Middle East & Africa: Saudi Arabia, UAE, South Africa

Company Analysis

Each company is evaluated based on:

Overview | Recent Developments | Revenue

Abbott Laboratories

Becton Dickinson and Company

Boston Scientific Corporation

Teleflex Incorporated

Medtronic Plc.

Johnson & Johnson

Edwards Lifesciences Corporation

Stryker Corporation

Final Thoughts

The global catheter market is entering a transformative decade. As chronic diseases rise and hospitals accelerate their transition to minimally invasive procedures, the demand for advanced catheter technologies will continue to surge. Innovations in bioabsorbable materials, real-time imaging, robotic guidance, and infection-resistant coatings are reshaping clinical decision-making and improving patient outcomes worldwide.

With markets such as China, Germany, Brazil, and the UAE rapidly expanding and global leaders investing heavily in R&D, the catheter industry is poised for sustained growth through 2033—delivering safer, smarter, and more patient-friendly solutions across the healthcare ecosystem.